Nevertheless, the CD8+ T cell in the TME might not be efficient to eliminate EBV-infected cells, since decreased numbers of central and effector memory CD8+ T lymphocytes were found among EBV + DLBCL patients [95]. This evidence concerns the gene CD8A and diffuse large B-cell lymphoma.